UK Government Trials Weight-Loss Jabs to Tackle Unemployment
The initiative aims to reduce obesity-related unemployment, but faces criticism and overwhelming demand on NHS resources.
- Health Secretary Wes Streeting announced a trial of weight-loss drugs, in partnership with Eli Lilly, to address obesity and unemployment.
- The initiative is part of a £279 million investment in the UK life sciences sector to develop new treatments and assess their impact on work productivity.
- Critics argue that the plan oversimplifies the complex causes of unemployment and that weight-loss jabs alone cannot solve economic deprivation.
- The NHS is struggling to meet the high demand for these drugs, with warnings from healthcare professionals about overstretched resources.
- Public opinion is divided, with a YouGov poll showing more support among Labour voters for the rollout of weight-loss jabs to help the unemployed.
The Telegraph 
BBC 
Evening Standard 
The Week 
The Guardian 
New Statesman 
The Independent The Independent The Independent The Telegraph 
NDTV BBC The Independent 
The Times Evening Standard The Telegraph 
i The Independent 
Deutsche Welle BBC BBC The Independent 
CNBC The Times The Telegraph 
Hindustan Times 
Sky News Evening Standard Evening Standard The Telegraph The Times BBC i The Guardian Evening Standard The Telegraph Sky News 
